Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Schut

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Mammary Gland Biology and Neoplasia|November 16, 2019
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in MiceLisette M Cornelissen, Linda Henneman, Anne Paulien Drenth, et al.
Nucleic Acids Research|June 3, 2017
Identifying transposon insertions and their effects from RNA-sequencing dataJulian R de Ruiter, Sjors M Kas, Eva Schut, et al.
The Journal of Pathology|November 21, 2009
A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesisBastiaan Evers, Ewoud N Speksnijder, Eva Schut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumorsBastiaan Evers, Eva Schut, Eline van der Burg, et al.
BMC Cancer|August 26, 2010
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancersHenne Holstege, Erik van Beers, Arno Velds, et al.
Cell Reports|August 16, 2016
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular CarcinomaMirjam C Boelens, Micha Nethe, Sjoerd Klarenbeek, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Genome Research|August 20, 2011
High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumorsMarco J Koudijs, Christiaan Klijn, Louise van der Weyden, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Genome Biology|October 15, 2010
Somatic structural rearrangements in genetically engineered mouse mammary tumorsIgnacio Varela, Christiaan Klijn, Phillip J Stephens, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Mammary Gland Biology and Neoplasia|November 16, 2019
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in MiceLisette M Cornelissen, Linda Henneman, Anne Paulien Drenth, et al.
Nucleic Acids Research|June 3, 2017
Identifying transposon insertions and their effects from RNA-sequencing dataJulian R de Ruiter, Sjors M Kas, Eva Schut, et al.
The Journal of Pathology|November 21, 2009
A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesisBastiaan Evers, Ewoud N Speksnijder, Eva Schut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumorsBastiaan Evers, Eva Schut, Eline van der Burg, et al.
BMC Cancer|August 26, 2010
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancersHenne Holstege, Erik van Beers, Arno Velds, et al.
Cell Reports|August 16, 2016
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular CarcinomaMirjam C Boelens, Micha Nethe, Sjoerd Klarenbeek, et al.
International Journal of Cancer|August 2, 2014
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activationFloris H Groenendijk, Wouter W Mellema, Eline van der Burg, et al.
Genome Research|August 20, 2011
High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumorsMarco J Koudijs, Christiaan Klijn, Louise van der Weyden, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Genome Biology|October 15, 2010
Somatic structural rearrangements in genetically engineered mouse mammary tumorsIgnacio Varela, Christiaan Klijn, Phillip J Stephens, et al.
Pageof 2